BridgeMD
New treatment option for Cancer
Official title Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors
ClinicalTrials.gov ID: NCT07390045
What this study is testing
- What it's testing
- The objective of this study is to assess the preliminary effects of an integrated exercise and cognitive rehabilitation intervention (ECO), an exercise intervention (EXCAP), and a cognitive rehabilitation intervention (MAAT) as compared to usual care on objective cognition (Trail Making Test).
- Time commitment: about 10 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age ≥65 years (from date of consent, confirmed on the electronic medical record)
- A diagnosis of any cancer
- Have completed curative intent treatments
- Patients on endocrine therapies are allowed to enroll
- Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allowed to enroll if they have completed...
You likely can't join if
- Any physical, psychological, or social impairments that would interfere with a patient's ability to participate in the study as determined by the...
- Unwilling to complete study procedures
See the full eligibility criteria
- Age ≥65 years (from date of consent, confirmed on the electronic medical record)
- A diagnosis of any cancer
- Have completed curative intent treatments
- Patients on endocrine therapies are allowed to enroll
- Patients with hematologic malignancies after autologous or allogeneic stem cell transplant are allowed to enroll if they have completed curative-intent treatment
- Answered "yes" to the verbal question "Do you have concerns about memory or other thinking abilities following your cancer treatment?"
- Able to speak English (interventions are available in English only)
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-3#
- No medical contraindications to exercise#
- Able to walk 4 meters#
- Able to provide informed consent#
- Confirmed through eligibility confirmation with the patient's oncologist or their designee
- Any physical, psychological, or social impairments that would interfere with a patient's ability to participate in the study as determined by the patient's oncologist or their designee
- Unwilling to complete study procedures
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.